FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2406005384> ?p ?o ?g. }

• W2406005384 endingPage "39822" @default.
• W2406005384 startingPage "39809" @default.
• W2406005384 abstract "Defining biomarkers that predict therapeutic effects and adverse events is a crucial mandate to guide patient selection for personalized cancer treatments. In the present study, we applied a pharmacometabolomics approach to identify biomarkers potentially associated with pathological complete response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer patients. Based on histological response the 34 patients enrolled in the study were subdivided into two groups: good responders (n = 15) and poor responders (n = 19). The pre-treatment serum targeted metabolomics profile of all patients were analyzed by liquid chromatography tandem mass spectrometry and the differences in the metabolomics profile between the two groups was investigated by multivariate partial least squares discrimination analysis. The most relevant metabolites that differentiate the two groups of patients were spermidine and tryptophan. The Good responders showed higher levels of spermidine and lower amounts of tryptophan compared with the poor responders (p < 0.001, q < 0.05). The serum level of these two metabolites identified patients who achieved a pathological complete response with a sensitivity of 90% [0.79-1.00] and a specificity of 0.87% [0.67-1.00]. These preliminary results support the role played by the individual patients' metabolism in determining the response to cancer treatments and may be a useful tool to select patients that are more likely to benefit from the trastuzumab-paclitaxel treatment." @default.
• W2406005384 created "2016-06-24" @default.
• W2406005384 creator A5008529443 @default.
• W2406005384 creator A5015626227 @default.
• W2406005384 creator A5024798356 @default.
• W2406005384 creator A5029995182 @default.
• W2406005384 creator A5039879267 @default.
• W2406005384 creator A5062077189 @default.
• W2406005384 creator A5066013189 @default.
• W2406005384 creator A5075663363 @default.
• W2406005384 creator A5078712050 @default.
• W2406005384 creator A5088789126 @default.
• W2406005384 date "2016-05-19" @default.
• W2406005384 modified "2023-10-18" @default.
• W2406005384 title "Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer" @default.
• W2406005384 cites W1964862438 @default.
• W2406005384 cites W1968430975 @default.
• W2406005384 cites W1968593126 @default.
• W2406005384 cites W1975778730 @default.
• W2406005384 cites W1976327004 @default.
• W2406005384 cites W1980046832 @default.
• W2406005384 cites W1988088217 @default.
• W2406005384 cites W1992234802 @default.
• W2406005384 cites W2009977534 @default.
• W2406005384 cites W2020169376 @default.
• W2406005384 cites W2025569212 @default.
• W2406005384 cites W2027542837 @default.
• W2406005384 cites W2032880834 @default.
• W2406005384 cites W2034410132 @default.
• W2406005384 cites W2034669913 @default.
• W2406005384 cites W2037013151 @default.
• W2406005384 cites W2039343804 @default.
• W2406005384 cites W2040935952 @default.
• W2406005384 cites W2045324973 @default.
• W2406005384 cites W2045731346 @default.
• W2406005384 cites W2053074390 @default.
• W2406005384 cites W2053124968 @default.
• W2406005384 cites W2059074147 @default.
• W2406005384 cites W2061156796 @default.
• W2406005384 cites W2062151959 @default.
• W2406005384 cites W2068115463 @default.
• W2406005384 cites W2079212574 @default.
• W2406005384 cites W2079529928 @default.
• W2406005384 cites W2084415324 @default.
• W2406005384 cites W2099624091 @default.
• W2406005384 cites W2123754509 @default.
• W2406005384 cites W2136780652 @default.
• W2406005384 cites W2141662174 @default.
• W2406005384 cites W2143738177 @default.
• W2406005384 cites W2144405588 @default.
• W2406005384 cites W2147415463 @default.
• W2406005384 cites W2149908785 @default.
• W2406005384 cites W2151262170 @default.
• W2406005384 cites W2151733225 @default.
• W2406005384 cites W2153907477 @default.
• W2406005384 cites W2165139474 @default.
• W2406005384 cites W2167580059 @default.
• W2406005384 cites W2318605753 @default.
• W2406005384 cites W2334822634 @default.
• W2406005384 cites W2395720723 @default.
• W2406005384 cites W2405420768 @default.
• W2406005384 doi "https://doi.org/10.18632/oncotarget.9489" @default.
• W2406005384 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5129972" @default.
• W2406005384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27223427" @default.
• W2406005384 hasPublicationYear "2016" @default.
• W2406005384 type Work @default.
• W2406005384 sameAs 2406005384 @default.
• W2406005384 citedByCount "62" @default.
• W2406005384 countsByYear W24060053842016 @default.
• W2406005384 countsByYear W24060053842017 @default.
• W2406005384 countsByYear W24060053842018 @default.
• W2406005384 countsByYear W24060053842019 @default.
• W2406005384 countsByYear W24060053842020 @default.
• W2406005384 countsByYear W24060053842021 @default.
• W2406005384 countsByYear W24060053842022 @default.
• W2406005384 countsByYear W24060053842023 @default.
• W2406005384 crossrefType "journal-article" @default.
• W2406005384 hasAuthorship W2406005384A5008529443 @default.
• W2406005384 hasAuthorship W2406005384A5015626227 @default.
• W2406005384 hasAuthorship W2406005384A5024798356 @default.
• W2406005384 hasAuthorship W2406005384A5029995182 @default.
• W2406005384 hasAuthorship W2406005384A5039879267 @default.
• W2406005384 hasAuthorship W2406005384A5062077189 @default.
• W2406005384 hasAuthorship W2406005384A5066013189 @default.
• W2406005384 hasAuthorship W2406005384A5075663363 @default.
• W2406005384 hasAuthorship W2406005384A5078712050 @default.
• W2406005384 hasAuthorship W2406005384A5088789126 @default.
• W2406005384 hasBestOaLocation W24060053841 @default.
• W2406005384 hasConcept C121608353 @default.
• W2406005384 hasConcept C126322002 @default.
• W2406005384 hasConcept C143998085 @default.
• W2406005384 hasConcept C207886595 @default.
• W2406005384 hasConcept C2777292972 @default.
• W2406005384 hasConcept C2778292576 @default.
• W2406005384 hasConcept C2779786085 @default.
• W2406005384 hasConcept C2781197716 @default.
• W2406005384 hasConcept C530470458 @default.
• W2406005384 hasConcept C55493867 @default.

• next